Roth Capital initiates Abeona Therapeutics at Buy
Roth Capital initiated coverage on Abeona Therapeutics with a $17.00 price target, reported /TradingView News.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.